By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Elixir Medical 

870 Hermosa Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-636-2000 Fax: n/a


SEARCH JOBS


Industry
Medical Device






Company News
Successful Live Case Demonstration Of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System At EuroPCR 5/21/2014 6:45:12 AM
Elixir Medical's Breakthrough Coronary Scaffold System Receives CE Mark Approval 5/13/2014 6:50:30 AM
Elixir Medical To Present At J.P. Morgan Healthcare Conference 1/6/2014 6:52:02 AM
Elixir Medical Announces Excellent 1-Year Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System 10/31/2013 7:47:22 AM
Elixir Medical Announces Outstanding Two-Year Results From the EXCELLA BD Randomized Clinical Trial for the CE Mark-Approved DESyne® BD System With Biodegradable Polymer Coating 5/24/2013 10:14:22 AM
Elixir Medical Announces Excellent Six-Month Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System at Late Breaking Clinical Trial Session of EuroPCR 5/21/2013 10:47:07 AM
Elixir Medical's DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System CE Marked 5/15/2013 7:21:22 AM
Elixir Medical Goes Head-to-Head Against Medtronic, Inc. (MDT) With Its DESyne Nx DES Study 5/14/2013 9:01:08 AM
Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne® Nx Novolimus Eluting Coronary Stent System in the United States 5/8/2013 11:06:04 AM
Elixir Medical to Present at J.P. Morgan Healthcare Conference 12/21/2012 6:25:42 AM
1234
//-->